CRYAB is also categorized as a marker for lower overall survival in cancers such as renal cell carcinoma, osteosarcoma, colorectal, hepatocellular carcinoma, gastric, ovarian, and non-small cell lung cancer [4]. This evidence concerns the gene CRYAB and osteosarcoma.